Doctor profile · Federal record

Dr. Gary Rolband, MD

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Charlotte, NC

  • NPI 1730106386
  • Accepts Medicare
  • 40 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
6060 Piedmont Row Dr S Fl 6
Charlotte, NC 282873884
(704) 489-3094
Additional location
630 Matthews Township Pkwy
Matthews, NC 281055322
(704) 495-6020
Mailing address
5960 Fairview RD Ste 500
Charlotte, NC 282103113

Credentials & registration

NPPES · NUCC
NPI registered
July 2006 — 20 yrs on file
Profile last updated
May 13, 2025
Year of graduation
1986 — 40 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
North Carolina #37935
Medicaid (3)
SC #N37935 · NC #1730106386 · NC #8973024

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1730106386. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
11,115
Distinct HCPCS
10
Medicare allowed
$361,298
HCPCS Description Services Patients Avg allowed
J0897 Injection, denosumab, 1 mg 6,240 71 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 1,064 610 $121
84443 Blood test, thyroid stimulating hormone (tsh) 472 322 $16
83036 Hemoglobin a1c level 468 303 $9
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes 464 237 $52
84439 Thyroxine (thyroid chemical), free 428 286 $9
82306 Vitamin d-3 level 297 224 $29
80048 Blood test, basic group of blood chemicals (calcium, total) 272 200 $8
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 249 139 $34
80061 Blood test, lipids (cholesterol and triglycerides) 153 129 $13

In context: peer comparison

Among 15 peers in Charlotte Endocrinology, Diabetes & Metabolism Physician, average services per provider: 321. This provider delivers 35× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,183
Transactions
43
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Tandem Diabetes Care, INC. 2 $169.11
Lilly USA, LLC 6 $126.25
Amgen INC. 5 $104.32
Radius Health, INC. 3 $74.14
Sanofi-Aventis U.S. LLC 3 $73.70
Novo Nordisk INC 4 $73.68
Amneal Pharmaceuticals LLC 3 $72.12
Novartis Pharmaceuticals Corporation 2 $57.33
Ibsa Pharma INC. 3 $56.83
Insulet Corporation 2 $55.92
Corcept Therapeutics 2 $44.24
Boehringer Ingelheim Pharmaceuticals, INC. 2 $42.89
Medtronic, INC. 2 $38.19
Abbvie INC. 2 $32.78
Tolmar, INC. 2 $29.16

By nature of payment

Food and Beverage
$1,183

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,482
Patients
697
Total drug cost
$896,043
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 588 168 $8,063
Synthroid (Levothyroxine Sodium) Brand 260 73 $25,006
Metformin Hcl ER (Metformin Hcl) Brand 197 67 $3,398
Ozempic (Semaglutide) Brand 187 41 $275,816
Trulicity (Dulaglutide) Brand 179 42 $310,305
Pioglitazone Hcl Generic 167 47 $2,223
Atorvastatin Calcium Generic 165 44 $2,592
Farxiga (Dapagliflozin Propanediol) Brand 108 19 $106,402
Metformin Hcl Generic 103 29 $1,075
Liothyronine Sodium Generic 100 35 $4,901

Frequently asked questions

Auto-generated from federal data
What is Dr. Gary Rolband's medical specialty?
Dr. Gary Rolband practices Endocrinology, Diabetes & Metabolism Physician in Charlotte, NC.
Where does Dr. Gary Rolband practice?
Dr. Gary Rolband practices at 6060 Piedmont Row Dr S Fl 6, Charlotte, NC 282873884. Office phone: 7044893094.
What is Dr. Gary Rolband's NPI?
Dr. Gary Rolband's National Provider Identifier (NPI) is 1730106386, issued by NPPES.
Does Dr. Gary Rolband accept Medicare assignment?
Yes. Dr. Gary Rolband accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Gary Rolband commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Blood test, thyroid stimulating hormone (tsh) (HCPCS 84443). Source: CMS Medicare Physician & Other Practitioners file.